1. Home
  2. EMBC vs CAPL Comparison

EMBC vs CAPL Comparison

Compare EMBC & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • CAPL
  • Stock Information
  • Founded
  • EMBC 1924
  • CAPL 1992
  • Country
  • EMBC United States
  • CAPL United States
  • Employees
  • EMBC N/A
  • CAPL N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • CAPL Oil Refining/Marketing
  • Sector
  • EMBC Health Care
  • CAPL Energy
  • Exchange
  • EMBC Nasdaq
  • CAPL Nasdaq
  • Market Cap
  • EMBC 788.4M
  • CAPL 793.6M
  • IPO Year
  • EMBC N/A
  • CAPL 2012
  • Fundamental
  • Price
  • EMBC $15.11
  • CAPL $20.53
  • Analyst Decision
  • EMBC Buy
  • CAPL
  • Analyst Count
  • EMBC 2
  • CAPL 0
  • Target Price
  • EMBC $18.50
  • CAPL N/A
  • AVG Volume (30 Days)
  • EMBC 507.0K
  • CAPL 24.1K
  • Earning Date
  • EMBC 08-08-2025
  • CAPL 11-05-2025
  • Dividend Yield
  • EMBC 3.90%
  • CAPL 10.23%
  • EPS Growth
  • EMBC 18.26
  • CAPL 100.77
  • EPS
  • EMBC 1.42
  • CAPL 1.13
  • Revenue
  • EMBC $1,102,500,000.00
  • CAPL $3,522,840,000.00
  • Revenue This Year
  • EMBC N/A
  • CAPL N/A
  • Revenue Next Year
  • EMBC N/A
  • CAPL N/A
  • P/E Ratio
  • EMBC $10.82
  • CAPL $18.22
  • Revenue Growth
  • EMBC N/A
  • CAPL N/A
  • 52 Week Low
  • EMBC $9.20
  • CAPL $19.50
  • 52 Week High
  • EMBC $21.48
  • CAPL $25.73
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 66.06
  • CAPL 45.39
  • Support Level
  • EMBC $14.51
  • CAPL $20.30
  • Resistance Level
  • EMBC $15.44
  • CAPL $20.67
  • Average True Range (ATR)
  • EMBC 0.50
  • CAPL 0.48
  • MACD
  • EMBC -0.04
  • CAPL -0.02
  • Stochastic Oscillator
  • EMBC 79.59
  • CAPL 29.72

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About CAPL CrossAmerica Partners LP Common Units representing limited partner interests

CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.

Share on Social Networks: